Clinical Updates

Seniors in the U.S. are prescribed at least one antibiotic each every year, on average - but the rate of… »   

A study of Medicare data suggests there was wide variation in antibiotic prescribing for older patients based on geography and… »   

China’s Bright Dairy & Food Co Ltd has been ordered by the Shanghai government to recall a cheese product for… »   

Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of… »   

Regulators warned L’Oreal SA, the world’s biggest cosmetics group, to stop advertising skincare products using language that makes them sound… »   

Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the… »   

A small trial of Peregrine Pharmaceuticals Inc’s experimental drug, bavituximab, showed that it doubled the length of time lung cancer… »   

The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone… »   

German healthcare conglomerate Fresenius has dropped its attempt to take over Rhoen-Klinikum after two other companies bought stakes to block… »   

A new drug designed to treat advanced prostate cancer that isn’t responding to other therapies received U.S. Food and… »   

A prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and… »   

U.S. drug reviewers questioned whether Novartis AG’s experimental inhaled antibiotic powder truly helped cystic fibrosis patients breathe better, according to… »   

Johnson & Johnson said an application to gain approval for a new usage of its prostate cancer treatment Zytiga won… »   

MUNICH: The expiry of patents on profitable heart medicines is soon going to erode one of the main sources of… »   

Abbott Laboratories Inc. won a U.S. panel’s support Tuesday for wider use of its blockbuster Humira drug in a type… »